By MedTruth Editors The U.S. Meals and Drug Administration (Fda) has declared that its latest regulatory framework is inadequate to management merchandise that contains cannabidiol (CBD), and as a consequence, the company will modify its regulatory oversight. The late January announcement describes how the company intends to harmony the consumer’s need for CBD items with […]
